HTA235 Comparative Narrative Review of Oncology Value Assessment Frameworks: Enfortumab Vedotin (EV) for Treatment of Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1918
https://www.valueinhealthjournal.com/article/S1098-3015(23)05048-9/fulltext
Title :
HTA235 Comparative Narrative Review of Oncology Value Assessment Frameworks: Enfortumab Vedotin (EV) for Treatment of Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05048-9&doi=10.1016/j.jval.2023.09.1918
First page :
Section Title :
Open access? :
No
Section Order :
11361